Partner Liane Peterson was quoted in a Bloomberg Law article, “Rush for Generic Go-Ahead on Novel Drugs Roils Pharma Industry,” about the growth in the number of generic drugmakers seeking to bring competing versions of brand name products to market as quickly as possible.
Peterson said the trend has led to more smaller players jumping in to be first-filers on profitable drugs, which “would suggest the bigger players don’t want to share the market with anyone else.”
People
Related News
January 2, 2026
In the News
Nicholas O'Keefe on DExit Movement
Foley & Lardner LLP partner Nicholas O’Keefe examined whether there were lessons to be learnt from the Delaware Supreme Court’s recent decision reinstating Elon Musk’s performance award, in Agenda, a Financial Times publication.
January 2, 2026
In the News
Jason Mehta and Lauren Carboni Quoted on Major Health Care AI Cases
Foley & Lardner LLP partner Jason Mehta and senior counsel Lauren Carboni discuss significant upcoming health care AI cases in the Law360 article, “The High-Stakes Healthcare AI Battles To Watch In 2026."
January 2, 2026
In the News
Nicholas Ellis and Vanessa Miller Assess Transportation Policy Trends
Foley & Lardner LLP partners Nicholas Ellis and Vanessa Miller highlighted tariff transportation policy developments in the Law360 article, “Transportation Regulation, Legislation To Watch In 2026.”